共 495 条
[1]
Tang Y(2020)Cytokine storm in COVID-19: the current evidence and treatment strategies Front Immunol 11 1708-422
[2]
Liu J(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 8 420-550
[3]
Zhang D(2017)New fronts emerge in the influenza cytokine storm Semin Immunopathol 39 541-127
[4]
Xu Z(2018)Cytokine release syndrome J Immunother Cancer 6 56-1062
[5]
Ji J(2020)Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 J Allergy Clin Immunol 146 119-136
[6]
Wen C(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 395 1054-1948
[7]
Xu Z(2020)Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 J Allergy Clin Immunol 146 128-727
[8]
Shi L(2020)Immunosuppression drug-related and clinical manifestation of coronavirus disease 2019: a therapeutical hypothesis Am J Transplant 20 1947-947
[9]
Wang Y(2014)IL-6 biology: implications for clinical targeting in rheumatic disease Nat Rev Rheumatol 10 720-328
[10]
Zhang J(2018)FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome Oncologist. 23 943-10975